Literature DB >> 2297460

Single dose pharmacokinetics and pharmacodynamics of oral oxazepam during concomitant administration of propranolol and labetalol.

J Sonne1, M Døssing, S Loft, K L Olesen, A Vollmer-Larsen, M A Victor, O Hamberg, H Thyssen.   

Abstract

1. The oral kinetics of oxazepam after a single 15 mg oral dose was investigated in six healthy volunteers before and during concomitant administration of the beta-adrenoceptor antagonists propranolol (80 mg) and labetalol (200 mg) (racemates). 2. A possible pharmacodynamic interaction between oxazepam and the beta-adrenoceptor antagonists was examined using a simple reaction time test (SRT) and by measurement of postural sway. 3. The kinetics of oxazepam were not affected significantly by propranolol or labetalol, although oxazepam and labetalol share the glucuronidation pathway. 4. The SRT was increased by combination of both beta-adrenoceptor antagonists with oxazepam, with the greatest increase after the coadministration of oxazepam with propranolol. Administration of the beta-adrenoceptor antagonists alone had no significant effect. 5. Postural sway was affected significantly only by the combination of oxazepam and propranolol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297460      PMCID: PMC1380058          DOI: 10.1111/j.1365-2125.1990.tb03599.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Bioavailability and pharmacokinetics of oxazepam.

Authors:  J Sonne; S Loft; M Døssing; A Vollmer-Larsen; K L Olesen; M Victor; F Andreasen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  The influence of propranolol on postural stability.

Authors:  O Lidegaard; E C Jansen; T Korsgaard Larsen
Journal:  Acta Neurol Scand       Date:  1984-06       Impact factor: 3.209

3.  Quantitative Romberg's test. Measurement and computer calculation of postural stability.

Authors:  E C Jansen; R E Larsen; M B Olesen
Journal:  Acta Neurol Scand       Date:  1982-07       Impact factor: 3.209

4.  Effects of metoprolol and propranolol on theophylline elimination.

Authors:  K A Conrad; D W Nyman
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

5.  Effects of atenolol and propranolol on human performance and subjective feelings.

Authors:  A A Landauer; D A Pocock; F W Prott
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

6.  Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

7.  The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

8.  Central effects of single oral doses of propranolol in man.

Authors:  S A Salem; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

Review 9.  Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.

Authors:  E P MacCarthy; S S Bloomfield
Journal:  Pharmacotherapy       Date:  1983 Jul-Aug       Impact factor: 4.705

10.  Impairment of antipyrine clearance in humans by propranolol.

Authors:  D J Greenblatt; K Franke; D H Huffman
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  2 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 2.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.